Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
Background: With the new highly active drugs available for people with multiple sclerosis
(pwMS), vaccination becomes an essential part of the risk management strategy Objective …
(pwMS), vaccination becomes an essential part of the risk management strategy Objective …
Safety of COVID-19 vaccines in multiple sclerosis: a systematic review and meta-analysis
Background Data are sparse regarding the safety of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccines in patients with multiple sclerosis (MS). Objective To …
coronavirus 2 (SARS-CoV-2) vaccines in patients with multiple sclerosis (MS). Objective To …
[HTML][HTML] Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: knowns and unknowns
The novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …
COVID-19 vaccine does not increase the risk of disease flare-ups among patients with autoimmune and immune-mediated diseases
Background: Reports describing post-vaccine autoimmune phenomena, in previously
healthy individuals, increased the concerns regarding the risk of disease flare-ups in …
healthy individuals, increased the concerns regarding the risk of disease flare-ups in …
Neurological autoimmune diseases following vaccinations against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2): A follow‐up study
S Doubrovinskaia, CM Mooshage… - European journal of …, 2023 - Wiley Online Library
Background and purpose Population‐based studies suggest severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) vaccines may trigger neurological autoimmunity …
syndrome coronavirus 2 (SARS‐CoV‐2) vaccines may trigger neurological autoimmunity …
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
D Stastna, I Menkyova, J Drahota, T Hrnciarova… - Multiple sclerosis and …, 2022 - Elsevier
Background COVID-19 vaccination and infection are speculated to increase the activity of
immune-mediated diseases, including multiple sclerosis (MS) and neuromyelitis optica …
immune-mediated diseases, including multiple sclerosis (MS) and neuromyelitis optica …